Ji X D, Gallo-Rodriguez C, Jacobson K A
Molecular Recognition Section, National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1994 Aug 30;203(1):570-6. doi: 10.1006/bbrc.1994.2220.
A newly synthesized, chemically reactive adenosine derivative, N6-(3-isothiocyanatobenzyl)adenosine-5'-N-methyluronamide, was found to bind selectively to A3 receptors. Ki values for this isothiocyanate derivative in competition binding at rat brain A1, A2a, and A3 receptors were 145, 272 and 10.0 nM, respectively. A preincubation with this derivative resulted in irreversible inhibition of radioligand binding at rat A3 receptors in membranes of transfected CHO cells or RBL-2H3 mast cells, but not at rat A1 or A2a receptors. The loss of binding sites for 0.1 nM [125I]N6-(4-aminobenzyl)adenosine-5'-N-methyluronamide, a high affinity A3 receptor radioligand, in transfected CHO cell membranes was concentration-dependent with an IC50 of 50 nM. No change was observed in the Kd value of the remaining A3 receptor sites. The inhibition was also insensitive to theophylline (1 mM), consistent with the pharmacology of rat A3 receptors. Structurally similar adenosine analogues lacking the chemically reactive isothiocyanate group failed to irreversibly inhibit A3-binding.
一种新合成的、具有化学反应活性的腺苷衍生物,N6-(3-异硫氰酸苄基)腺苷-5'-N-甲基脲酰胺,被发现能选择性地与A3受体结合。该异硫氰酸酯衍生物在大鼠脑A1、A2a和A3受体竞争结合中的Ki值分别为145、272和10.0 nM。用该衍生物预孵育导致转染的CHO细胞或RBL-2H3肥大细胞膜中大鼠A3受体上放射性配体结合的不可逆抑制,但对大鼠A1或A2a受体无此作用。在转染的CHO细胞膜中,0.1 nM [125I]N6-(4-氨基苄基)腺苷-5'-N-甲基脲酰胺(一种高亲和力A3受体放射性配体)结合位点的丧失呈浓度依赖性,IC50为50 nM。剩余A3受体位点的Kd值未观察到变化。该抑制作用对茶碱(1 mM)也不敏感,这与大鼠A3受体的药理学特性一致。缺乏化学反应性异硫氰酸酯基团的结构相似的腺苷类似物未能不可逆地抑制A3结合。